Novavax NVAX announced that it has started dosing participants in the phase III study evaluating its experimental ...

Shares of Novavax rose nearly 1% after the open on Friday, continuing a positive streak with gains expected for the third ...

Novavax Inc (NVAX) stock saw a modest uptick, ending the day at $9.02 which represents a slight increase of $0.20 or 2.27% from the prior close of $8.82. The stock opened at $8.77 and touched a low of ...

Novavax (NVAX) announced progress in Q4 advancing its corporate growth strategy through its partnership with Sanofi (SNY). The company has ...

Novavax (NVAX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Vernon Bernardino, an analyst from H.C. Wainwright, maintained the Buy rating on Novavax (NVAX – Research Report). The associated price target ...

On Tuesday, Novavax Inc (NVAX) stock saw a decline, ending the day at $8.77 which represents a decrease of $-0.30 or -3.31% from the prior close of $9.07. The stock opened at $9.1 and touched a low of ...

Shares of Novavax Inc. NVAX slid 3.31% to $8.77 Tuesday, on what proved to be an all-around poor trading session for the ...

Last week’s 6.3% gain means that institutional investors were on the positive end of the spectrum even as the company has shown strong longer-term trends. The gains from last week would have further ...

Novavax Inc. closed $15.04 short of its 52-week high ($23.86), which the company reached on June 6th.

Novavax, Inc. (NASDAQ:NVAX – Free Report) – Equities research analysts at Zacks Research dropped their FY2024 earnings ...

With the purchase of a plant in the Czech Republic, Novo Nordisk is saying “jak se máš” to hundreds of new employees—and ...